Larson Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$489K Buy
2,110
+1,401
+198% +$346K 0.01% 597
2026
Q2
$171K Buy
709
+281
+66% +$61.6K ﹤0.01% 911
2026
Q1
$80.9K Buy
428
+83
+24% +$14.5K ﹤0.01% 1094
2025
Q4
$58.6K Buy
345
+40
+13% +$6.13K ﹤0.01% 1162
2025
Q3
$40.2K Sell
305
-36
-11% -$4.32K ﹤0.01% 1251
2025
Q2
$36.2K Buy
341
+243
+248% +$26.4K ﹤0.01% 1204
2025
Q1
$12.2K Buy
98
+36
+58% +$4.7K ﹤0.01% 1558
2024
Q4
$7.64K Buy
62
+56
+933% +$6.6K ﹤0.01% 1565
2024
Q3
$668 Buy
6
+3
+100% +$329 ﹤0.01% 2068
2024
Q2
$320 Hold
3
– – ﹤0.01% 1948
2024
Q1
$361 Hold
3
– – ﹤0.01% 1586
2023
Q4
$369 Hold
3
– – ﹤0.01% 1598
2023
Q3
$388 Hold
3
– – ﹤0.01% 1598
2023
Q2
$372 Hold
3
– – ﹤0.01% 1470
2023
Q1
$439 Hold
3
– – ﹤0.01% 1422
2022
Q4
$478 Hold
3
– – ﹤0.01% 1371
2022
Q3
$0 Hold
3
– – ﹤0.01% 1347
2022
Q2
$0 Hold
3
– – ﹤0.01% 1247
2022
Q1
$0 Hold
3
– – ﹤0.01% 1111
2021
Q4
$0 Buy
+3
New +$394 ﹤0.01% 1128
2020
Q1
– Sell
-15
Closed -$2K – 595
2019
Q4
$2K Hold
15
– – ﹤0.01% 455
2019
Q3
$2K Hold
15
– – ﹤0.01% 437
2019
Q2
$2K Hold
15
– – ﹤0.01% 389
2019
Q1
$2K Hold
15
– – ﹤0.01% 380
2018
Q4
$2K Buy
+15
New +$2.22K ﹤0.01% 359

Other funds holding JAZZ

Larson Financial Group's JAZZ Position: Q3 2026 in Review

Larson Financial Group increased its Jazz Pharmaceuticals (JAZZ) stake by 198% in Q3 2026, buying an estimated $346K and bringing the position to 2,110 shares worth $489K. The position accounts for 0.01% of the portfolio, ranked #597.

Larson Financial Group first reported a position in JAZZ in Q4 2018 and has held it in 25 quarters since. 668 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Larson Financial Group held 2,110 shares of Jazz Pharmaceuticals worth $489K as of Q3 2026.
  • Larson Financial Group bought 1,401 Jazz Pharmaceuticals shares in Q3 2026, an estimated $346K.
  • Jazz Pharmaceuticals made up 0.01% of Larson Financial Group's portfolio in Q3 2026, its #597 holding.
  • Larson Financial Group first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 25 quarters since.
  • 668 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.